Furthermore, statistical analysis of public databases has confirmed that BIG3 correlates with prognosis in all subtypes of luminal-type breast cancer, suggesting its contribution to the progression and malignancy of the disease. This evidence concerns the gene ARFGEF3 and breast cancer.